3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Burkitt Lymphoma
22
Leukemia, Biphenotypic, Acute
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myeloid, Acute
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Osteosarcoma
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia
4
Down Syndrome
4
Blast Crisis
4
Lymphoma, Mantle-Cell
3
Lymphoma
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Rhabdoid Tumor
2
Recurrence
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Juvenile
2
Head and Neck Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Waldenstrom Macroglobulinemia
1
Urothelial Carcinoma of the Bladder
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Interventions
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
Thiotepa
1
Specimen Handling
1
Second-Look Surgery
1
Reoperation
1
Radiotherapy
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Choriocarcinoma
×
Methotrexate
×
90 days
×
Clear all
No trials found.